Dr. Alexa R. Meyer
Overview
Dr. Meyer is a fellowship-trained minimally invasive urologic surgeon. Having trained with world-renowned experts and pioneers of laparoscopic and robotic surgery, her clinical practice focuses on the diagnosis and treatment of prostate cancer and kidney cancer. Dr. Meyer's clinical interests and surgical expertise also include the treatment of enlarged prostate (BPH), kidney stones, ureteropelvic junction obstruction, and urothelial cancers of the kidney and ureter.Dr. Meyer graduated Phi Beta Kappa and Summa Cum Laude from Columbia University. She received her medical degree from Columbia University College of Physicians and Surgeons where she was elected to the prestigious Alpha Omega Alpha Society. She completed her internship in General Surgery and residency in Urology at the James Buchanan Brady Urological Institute at Johns Hopkins. She then completed a fellowship in minimally invasive urologic surgery at The Smith Institute for Urology at Northwell Health. She is currently the Director of Robotic Education and Associate Program Director at The Smith Institute for Urology at Lenox Hill.
Dr. Meyer is highly rated in 1 condition, according to our data. Her top areas of expertise are Renal Oncocytoma, Prostate Cancer, Renal Cell Carcinoma (RCC), Cystectomy, and Prostatectomy.
Her clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- PPO
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
135 Montague Street, 2nd Floor, Brooklyn, NY 11201
110 East 58th Street, 10th Floor, New York, NY 10022
Additional Areas of Focus
Dr. Meyer has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
CUIMC/Herbert Irving Pavilion
James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is highly rated in 25 conditions, according to our data. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Alison Moskowitz is a Hematologist and an Oncologist in New York, New York. Dr. Moskowitz is highly rated in 33 conditions, according to our data. Her top areas of expertise are T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.
Rockefeller Outpatient Pavilion
William Tap is an Oncologist in New York, New York. Dr. Tap is highly rated in 31 conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Angiosarcoma, Tissue Biopsy, and Liver Embolization. Dr. Tap is currently accepting new patients.
Frequently Asked Questions about Dr. Alexa R. Meyer
How do I make an appointment with Dr. Alexa R. Meyer?
You can book an appointment with Dr. Alexa R. Meyer by calling their office at 718-587-0020. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Alexa R. Meyer a top-rated expert for Renal Oncocytoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Alexa R. Meyer is classified as an Advanced expert for Renal Oncocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Alexa R. Meyer specialize in?
While Dr. Alexa R. Meyer is a Oncology, they have specific expertise in Renal Oncocytoma, Prostate Cancer, and Cystectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Alexa R. Meyer participate in research or clinical trials?
Yes. Dr. Alexa R. Meyer has published 34 articles and abstracts on conditions like Renal Oncocytoma. You can view a list of Dr. Alexa R. Meyer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Alexa R. Meyer accept my insurance?
Dr. Alexa R. Meyer accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 718-587-0020 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Renal OncocytomaDr. Meyer isAdvanced. Learn about Renal Oncocytoma.
- Experienced
- Bacterial ProstatitisDr. Meyer isExperienced. Learn about Bacterial Prostatitis.
- Bladder CancerDr. Meyer isExperienced. Learn about Bladder Cancer.
- CystectomyDr. Meyer isExperienced. Learn about Cystectomy.
- Familial Prostate CancerDr. Meyer isExperienced. Learn about Familial Prostate Cancer.
- HydronephrosisDr. Meyer isExperienced. Learn about Hydronephrosis.
- HypospadiasDr. Meyer isExperienced. Learn about Hypospadias.